[1]桂彤, 杨超, 何炳书, 等. 急性脊髓损伤早期应用大剂量甲基泼尼松龙辅助治疗效果观察[J]. 山东医药, 2016, 56(42): 65-66.
[2]曹鹏, 石长贵, 袁文, 等. 甲基强的松龙在急性脊髓损伤中的应用进展[J]. 中国脊柱脊髓杂志, 2015, 25(2): 174-178.
[3]朱庄臣, 焦伟, 蔡国栋, 等. 大剂量甲强龙治疗急性脊髓损伤后早期并发症的研究[J]. 中国矫形外科杂志, 2014, 22(16): 1454-1457.
[4]Brooks NP, Potts E, O`Toole J. Letter: The impact of guidelines on clinical practice: survey of the use of methylprednisolone for acute spinal cord injury[J]. Neurosurg, 2016, 79(3): E516-E520.
[5]Weiser T. Ambroxol: a CNS drug[J]? CNS Neurosci Ther, 2008, 14(1): 17-24.
[6]Gaida W, Klinder K, Arndt K, et al. Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain[J]. Neuropharmacol, 2005, 49(8): 1220-1227.
[7]Chandran V, Coppola G, Nawabi H, et al. A systems-level analysis of the peripheral nerve intrinsic axonal growth program[J]. Neuron, 2016, 89(5): 956-970.
[8]Mbori NJ, Chuan XY, Feng QX. Evaluation of the combination of methylprednisolone and tranilast after spinal cord injury in rat models[J]. J Korean Neurosurg Soc, 2016, 59(4): 334-340.
[9]王一吉, 周红俊, 李建军, 等. 脊髓损伤神经学分类国际标准检查表最新修订及解读[J].中国康复理论与实践, 2015, 21(8): 879-882.
[10]关骅, 陈学明. 脊髓损伤ASIA神经功能分类标准(2000年修订)[J]. 中国脊柱脊髓杂志, 2001, 11(3): 164.
[11]李小群, 杨利学, 吕正, 等. 椎弓根固定系统治疗胸腰椎骨折合并脊髓损伤57例分析[J]. 长春中医药大学学报, 2009, 25(5): 702-704.
[12]陈勇, 夏刚. Rho激酶抑制剂联合高压氧对胸腰椎骨折合并脊髓损伤术后神经功能恢复的效果观察[J]. 中国生化药物杂志, 2015, 35(10): 85-87.
[13]Lu GB, Niu FW, Zhang YC, et al. Methylprednisolone promotes recovery of neurological function after spinal cord injury: association with Wnt/β-catenin signaling pathway activation[J]. 2016, 11(11): 1816-1823.
[14]曹奇, 唐晓军, 李贵涛, 等. 围手术期应用甲基强的松龙与地塞米松对脊髓型颈椎病髓内高信号转归及临床意义的比较[J]. 中国矫形外科杂志, 2013, 21(3): 217-222.
[15]Celik H, Karatay M, Erdem Y, et al. The biochemical, histopathological and clinical comparison of the neuroprotective effects of subcutaneous adalimumab and intravenous methylprednisolone in an experimental compressive spinal cord trauma model [J]. Turk Neurosurg, 2016, 26(4): 622-631.
[16] Evaniew N, Noonan VK, Fallah N, et al. Methylprednisolone for the treatment of patients with acute spinal cord injuries: response[J]. J Neurotrauma, 2016, 33(10): 975-976.
[17]Afshari FT, Kappagantula S, Fawcett JW. Extrinsic and intrinsic factors controlling axonal regeneration after spinal cord injury[J]. Expert Rev Mol Med, 2009, 11: e37.
[18]Hollis ERⅡ. Axon guidance molecules and neural circuit remodeling after spinal cord injury[J]. Neurotherapeutics, 2016, 13(2): 360-369. |